The FDA has recently approved the first formulations of Sublingual Immunotherapy in the United States. Currently approved are two different formulations one for grass allergy and one for ragweed. It is likely that a formulation to treat dust mite allergy will also be approved in a couple of years. These come in the form of a dissolvable tablet that is placed under the tongue daily. Similar to allergy shots, sublingual immunotherapy exposes patients to the substances which they are allergic to in a way to decrease their sensitivity over time.
Who would benefit from these Sublingual Immunotherapy Tablets?